Quantcast
Home > Quotes > GNPX

Genprex, Inc. Common Stock (GNPX) Quote & Summary Data

GNPX 
$6.8989
*  
0.9011
11.55%
Get GNPX Alerts
*Delayed - data as of Jun. 19, 2018  -  Find a broker to begin trading GNPX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    GNPX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
Today's High / Low
$ 7.78 / $ 6.07
Share Volume
121,910
50 Day Avg. Daily Volume
370,475
Previous Close
$ 7.80
52 Week High / Low
$ 19.4499 / $ 3.84
Market Cap
95,873,503
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
-2.13

Intraday Chart

Shares Traded

Share Volume:
121,910
50 Day Avg. Daily Volume:
370,475

Trading Range

The current last sale of $6.8989 is 79.66% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 7.78 $ 19.4499
 Low: $ 6.07 $ 3.84

Company Description (as filed with the SEC)

Genprex(TM) is a clinical stage gene therapy company developing a new approach to treating cancer, based upon our novel proprietary technology platform, including our initial product candidate, Oncoprex(TM) immunogene therapy, or Oncoprex. Our platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.  ... More ...  

Nasdaq Official Price

Open Price:
$ 7.78
Open Date:
Jun. 19, 2018
Close Price:
$ 7.80
Close Date:
Jun. 19, 2018

Research Brokers before you trade

Want to trade FX?

Analyst Info